Yawei Xu

1.5k total citations
51 papers, 771 citations indexed

About

Yawei Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yawei Xu has authored 51 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Yawei Xu's work include Renal cell carcinoma treatment (7 papers), Epigenetics and DNA Methylation (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Yawei Xu is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Epigenetics and DNA Methylation (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Yawei Xu collaborates with scholars based in China, United States and Malaysia. Yawei Xu's co-authors include Yongjiao Yang, Kan Gong, Jingcheng Zhou, Kenan Zhang, Wuping Yang, Yanqing Gong, Yuxuan Song, Xiaoqiang Liu, Zedan Zhang and Yi Lü and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Lab on a Chip.

In The Last Decade

Yawei Xu

48 papers receiving 765 citations

Peers

Yawei Xu

PRM

EPIDE

Angela Zhang United States

Zi Ye China

Hong Seok Park South Korea

Mariusz Zimmer Poland

Stefania Canova Italy

M. Alexandra Monroy United States

H Bauer Germany

Yan Jin China

U. Cassens Germany

Angela Zhang United States

Yawei Xu

358 ×1.1

151 ×0.9

PRM

104 ×0.6

74 ×0.6

76 ×1.2

EPIDE

Citations per year, relative to Yawei Xu Yawei Xu (= 1×) peers Angela Zhang

Countries citing papers authored by Yawei Xu

Since Specialization

Citations

This map shows the geographic impact of Yawei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Xu more than expected).

Fields of papers citing papers by Yawei Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Xu. The network helps show where Yawei Xu may publish in the future.

Co-authorship network of co-authors of Yawei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Xu. A scholar is included among the top collaborators of Yawei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Xu. Yawei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Zedan, Yi Wang, Wuping Yang, et al.. (2024). Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort. iScience. 27(7). 110357–110357.

Xu, Yawei, Kenan Zhang, Yizhou Wang, et al.. (2023). Molecular classification and tumor microenvironment characteristics in pheochromocytomas. eLife. 12. 8 indexed citations

Yang, Wuping, Zedan Zhang, Lei Li, et al.. (2023). ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. Cell Death and Disease. 14(3). 212–212. 9 indexed citations

Xu, Yawei, Wuping Yang, Zedan Zhang, et al.. (2023). Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC. Molecular Diagnosis & Therapy. 27(6). 741–752. 1 indexed citations

Song, Zhao, Chong Xu, Jing Xiong, et al.. (2023). ASSOCIATION OF UNILATERAL LOW ANKLE-BRACHIAL INDEX AND BILATERAL LOW ANKLE-BRACHIAL INDEX WITH INCIDENT CARDIOVASCULAR DISEASE AND MORTALITY: THE NORTHERN SHANGHAI STUDY. Journal of Hypertension. 41(Suppl 3). e155–e155. 1 indexed citations

Su, Yang, et al.. (2023). Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China. Journal of Infection and Public Health. 16(3). 418–421. 2 indexed citations

Zhang, Kenan, Wuping Yang, Zedan Zhang, et al.. (2022). A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Oncology. 2022. 1–19. 4 indexed citations

Zhang, Zedan, Wuping Yang, Yawei Xu, et al.. (2022). Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma. Journal of Immunology Research. 2022. 1–19. 8 indexed citations

Zhang, Kenan, Wuping Yang, Kaifang Ma, et al.. (2022). Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions. Journal of Medical Genetics. 60(5). 477–483.

10.

Mohammed, Abdul‐Quddus, Hengbin Zhang, Lu Liu, et al.. (2022). Prognostic implication of coronary slow flow assessed by cTFC in patients with myocardial infarction with Non-obstructive coronary arteries. European Journal of Internal Medicine. 108. 74–80. 6 indexed citations

11.

Xu, Yawei, Jingcheng Zhou, Lei Li, et al.. (2022). FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. International Journal of Biological Sciences. 18(15). 5943–5962. 60 indexed citations

12.

Wang, Bo, Wenxin Kou, Hongwei Ji, et al.. (2022). Prognostic value of plasma adipokine chemerin in patients with coronary artery disease. Frontiers in Cardiovascular Medicine. 9. 968349–968349. 9 indexed citations

13.

Xu, Yawei, Lei Li, Wuping Yang, et al.. (2021). Association between vasectomy and risk of prostate cancer: a meta-analysis. Prostate Cancer and Prostatic Diseases. 24(4). 962–975. 4 indexed citations

14.

Zhang, Kenan, Wuping Yang, Kaifang Ma, et al.. (2021). Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients. Journal of Medical Genetics. 59(10). 951–956. 5 indexed citations

15.

Song, Yuxuan, et al.. (2020). Identification and verification of hub microRNAs in varicocele rats through high-throughput sequencing and bioinformatics analysis. Reproductive Toxicology. 98. 189–199. 7 indexed citations

16.

Liang, Zhen, Jun Zhu, Longlong Chen, et al.. (2019). Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta‐analysis and systematic review. Andrology. 8(3). 559–574. 15 indexed citations

17.

Liang, Zhen, Xiaoqiang Liu, Yongjiao Yang, et al.. (2019). Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis. BMC Cancer. 19(1). 1244–1244. 57 indexed citations

18.

Xu, Yawei, et al.. (2019). Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis. BMC Cancer. 19(1). 168–168. 14 indexed citations

19.

Xu, Yawei, et al.. (2018). Long noncoding RNA <em>XIST </em>promotes proliferation and invasion by targeting miR-141 in papillary thyroid carcinoma. OncoTargets and Therapy. Volume 11. 5035–5043. 19 indexed citations

20.

Xu, Yawei, et al.. (2017). miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma. Biomedicine & Pharmacotherapy. 98. 531–537. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact